
Conference Coverage
Latest News

FDA Approves Nufymco, Interchangeable Ranibizumab Biosimilar, for Retinal Diseases

AI-Enhanced Nasal Antiviral Platforms: A Promising Frontier in Influenza Prevention and Management

Refill Metrics vs. Real Outcomes: When Medication Adherence Doesn't Equal Better Health

A New Gut Feeling: Where Might Vonoprazan Fit in Therapy?

Orforglipron Shows Strong Weight Maintenance in Phase 3 ATTAIN-MAINTAIN Trial

Shorts










Podcasts
Videos
Continuing Education
All News

A high-fiber, plant-based diet shows promise in delaying multiple myeloma progression and enhancing metabolism and immune response in patients with precursor conditions.

Tracking your net worth monthly can shift your financial mindset and build lasting wealth.

The FDA approves Accrufer for children 10 and older, offering a well-tolerated solution for iron deficiency, enhancing pediatric health outcomes.

Researchers uncover how type 2 innate lymphoid (ILC2) and T helper 2 (Th2) cells in allergic asthma survive toxic environments, revealing potential new therapeutic strategies for treatment.

A series of workplace factors were found to increase the risk of long COVID, including close contact with colleagues and commuting through public transportation.

Vitamin D is vital for bone health and immune function, yet many Americans remain deficient.

Pharmacy technicians enhance patient safety and efficiency by mastering communication, situational awareness, and leadership skills.

The novel agent has demonstrated efficacy in symptomatic and less severe patients with obstructive hypertrophic cardiomyopathy in thorough phase 3 clinical trials.

Although both sex groups showed cognitive decline, women with chronic kidney disease (CKD) had significantly better cognitive scores than men.

T-DXd Granted Breakthrough Therapy Designation in Post-Neoadjuvant HER2-Positive Early Breast Cancer
Fam-trastuzumab deruxtecan-nxki (T-DXd) promises enhanced outcomes for HER2-positive early breast cancer patients post-neoadjuvant treatment.

Ribociclib shows higher early treatment modifications than palbociclib in HR+/HER2– breast cancer, emphasizing the need for proactive toxicity management.

The approval offers hope for improved lung function and new treatment options for patients.

Serotypes included in the pneumococcal 21-valent conjugate vaccine (PCV21) cause outsized disease and economic burden in Norwegian patients with pneumococcal disease.

Lessons learned from interprofessional spiritual training and the evolving role of palliative care pharmacists toward an integrated and patient-centric health care system.

Oncology pharmacists and the pharmaceutical industry can enhance patient care through improved support, education, and access to innovative treatments.

COVID-19 vaccination significantly lowers severe illness and preterm birth risks for pregnant individuals.

A technician-driven workflow implemented in a health system’s specialty pharmacy reduced high-cost oncology drug waste.

Explore essential supplement recommendations for older adults, including vitamin D, calcium, melatonin, and multivitamins, to enhance health and well-being.

Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
New agreements aim to align US drug prices with European standards, enhancing Medicaid savings and enabling direct consumer purchases.

Research highlights the critical link between chronic kidney disease (CKD) and uncontrolled gout, emphasizing a need for enhanced awareness and treatment strategies.

FDA approves Fesilty, a new fibrinogen concentrate, offering hope for effective treatment of congenital fibrinogen deficiency and acute bleeding episodes.

New clinical trial results highlight the effectiveness of enfortumab vedotin and pembrolizumab in improving survival for patients with muscle-invasive bladder cancer.

Pharmacy technicians enhance safety and efficiency in hazardous drug compounding.






























